arrow
C

Chia-Lin Tseng

sunnybrook health science center
H指数:33
被引数:3,442

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reirradiation outcomes following salvage conventionally fractionated Gamma Knife stereotactic radiotherapy (SFGK) to recurrent primary non-glial brain tumors

复发原发性非胶质脑肿瘤在行挽救性常规分次伽马刀立体定向放射治疗后再次照射的结局

2026-09-180
PRE
Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial

前列腺和盆腔SBRT,伴或不伴局部加量:多中心II期前瞻性临床试验结果

2026-09-010
PRE
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)

一项关于高剂量率(HDR)和低剂量率(LDR)近距离治疗作为单一疗法在局限性前列腺癌中的随机Ⅱ期试验:加拿大癌症试验组PR19(NCT02960087)初始试验组的分析

2025-09-080
PRE
3 MR-LINAC ON-LINE WEEKLY ADAPTIVE RADIOTHERAPY FOR HIGH GRADE GLIOMA (HGG): RESULTS FROM THE UNITED SINGLE ARM PHASE II TRIAL

3 MR-LINAC 在线每周自适应放射治疗用于高级别胶质瘤(HGG):来自单臂二期临床试验的结果

2025-08-310
OAAI
Prognostic factors for local failure and overall survival in patients with epidural disease at the cauda equina following stereotactic body radiotherapy: a clinical, anatomic and dosimetric analysis

骶尾部硬膜外病变立体定向体部放射治疗后的局部失败与总生存期的预后因素:一项临床、解剖和剂量学分析

2025-07-160
PRE
Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma

化学放射治疗期间表观扩散系数的时序变化:胶质母细胞瘤中用于监测肿瘤反应和预测空间复发的影像生物标志物

2025-03-260
OAAI
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials

两分次与五分次立体定向体部放射治疗对中危前列腺癌的比较:TOFFEE个体患者数据元分析,基于四项前瞻性试验

2025-02-010
OAAI
Spine Stereotactic Body Radiation Therapy in Geriatric Patients: Implications of Age and Dose on Iatrogenic Vertebral Compression Fracture Risk

老年患者脊柱立体定向体部放射治疗:年龄和剂量对医源性椎体压缩性骨折风险的影响

2024-11-011
OAAI
Is pulsed saturation transfer sufficient for differentiating radiation necrosis from tumor progression in brain metastases?
2024-07-291
OAAI
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)
2024-05-012
PRE